---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-232477"
form_type: "8-K"
ticker: "URGN"
cik: "0001668243"
company_name: "UroGen Pharma Ltd."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:45:02.229921+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# UroGen Pharma shareholders approve 2017 Plan amendment, elect directors, ratify auditor

## Summary
- Elected eight directors including Arie Belldegrun, Elizabeth Barrett, Cynthia M. Butitta, and Fred E. Cohen.
- Approved amendment to 2017 Equity Incentive Plan increasing authorized shares by 450,000.
- Approved grant of Performance Stock Units to CEO under the amended plan (13,115,279 for, 3,363,390 against).
- Advisory say-on-pay passed with 13,668,197 for, 3,118,618 against, 35,305 abstentions.
- Ratified PricewaterhouseCoopers LLP as independent auditor for next fiscal year (22,507,002 for, 16,731 against).

## SEC filing metadata
- accession: 0001193125-23-232477
- form_type: 8-K
- ticker: URGN
- cik: 0001668243
- company_name: UroGen Pharma Ltd.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/d485257d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-232477
- JSON: https://secwatch.observer/filing/0001193125-23-232477.json
- Plain text: https://secwatch.observer/filing/0001193125-23-232477.txt

## Key facts
- Shareholder Votes
  UroGen Pharma Ltd. shareholders approved Election of Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company’s next annual meeting of shareholders and until their successors are elected.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm
- Shareholder Votes
  UroGen Pharma Ltd. shareholders approved Engagement of PricewaterhouseCoopers LLP as independent auditor.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: Proposal 5 - Engagement of PricewaterhouseCoopers LLP as independent auditor. The shareholders approved the engagement of PricewaterhouseCoopers LLP as the Company’s independent auditor until the Company’s 2024 annual meeting of shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm
- Shareholder Votes
  UroGen Pharma Ltd. shareholders approved Performance Stock Units grant to CEO.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 3 – Performance Stock Units The shareholders approved a grant of Performance Stock Units to the Company’s Chief Executive Officer under the 2017 Amended Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm
- Shareholder Votes
  UroGen Pharma Ltd. shareholders approved Advisory vote on the compensation of the Company’s named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: Proposal 4 - Advisory vote on the compensation of the Company’s named executive officers. On an advisory basis, the shareholders approved the compensation paid to the Company’s named executive officers, as disclosed in the Company’s proxy statement for the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm
- Shareholder Votes
  UroGen Pharma Ltd. shareholders approved 2017 Amended Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 2 – 2017 Amended Plan. The shareholders approved the 2017 Amended Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668243/000119312523232477/0001193125-23-232477-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.